Are Miven Machine Tools Ltd latest results good or bad?

Feb 06 2026 07:28 PM IST
share
Share Via
Miven Machine Tools Ltd's latest results are concerning, with zero net sales for six consecutive quarters and a net loss of ₹0.15 crores, indicating significant financial distress and operational paralysis. The company has negative shareholder equity and ranks last among its peers, reflecting ongoing challenges in the market.
Miven Machine Tools Ltd's latest financial results for Q2 FY26 reflect a challenging operational environment. The company reported zero net sales for the sixth consecutive quarter, indicating a complete halt in revenue generation. The net loss for the quarter was ₹0.15 crores, which represents a marginal change from the previous quarter's loss of ₹0.17 crores. However, this change is primarily due to reduced cash burn rather than any operational recovery.
The company's financial position is concerning, with a book value per share of negative ₹18.37 and negative shareholder equity of ₹5.52 crores as of March 2025. This negative equity suggests significant financial distress and raises questions about the company's solvency. Despite maintaining a net cash position with a debt-to-equity ratio of -0.56x, the overall financial health is undermined by the persistent lack of revenue and operational activity. In terms of operational costs, Miven Machine Tools continues to incur employee costs of ₹0.05 crores per quarter, indicating that a minimal workforce remains on the payroll despite the absence of sales. The company's cumulative losses for the first half of FY26 stand at ₹0.32 crores, further emphasizing the lack of business activity. The stock performance over the past year shows a marginal return of 0.11%, significantly lagging behind the Sensex's gain of 6.77%. The company's market capitalization is relatively low at ₹26.00 crores, and it ranks last among its peers in the industrial manufacturing sector. Overall, Miven Machine Tools Ltd's financial results highlight a company in operational paralysis, with no clear path to recovery and multiple red flags regarding its financial stability. The company has seen an adjustment in its evaluation, reflecting the ongoing challenges it faces in the market.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News